These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 23175472)

  • 21. Lin-28B transactivation is necessary for Myc-mediated let-7 repression and proliferation.
    Chang TC; Zeitels LR; Hwang HW; Chivukula RR; Wentzel EA; Dews M; Jung J; Gao P; Dang CV; Beer MA; Thomas-Tikhonenko A; Mendell JT
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3384-9. PubMed ID: 19211792
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FLT3/ITD expression increases expansion, survival and entry into cell cycle of human haematopoietic stem/progenitor cells.
    Li L; Piloto O; Kim KT; Ye Z; Nguyen HB; Yu X; Levis M; Cheng L; Small D
    Br J Haematol; 2007 Apr; 137(1):64-75. PubMed ID: 17359372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-150:targeting MLL leukemia.
    Jiang X; Chen J
    Oncotarget; 2012 Nov; 3(11):1268-9. PubMed ID: 23175472
    [No Abstract]   [Full Text] [Related]  

  • 24. Mixed lineage rearranged leukaemia: pathogenesis and targeting DOT1L.
    Stein EM; Tallman MS
    Curr Opin Hematol; 2015 Mar; 22(2):92-6. PubMed ID: 25635757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The molecular functions of common and atypical MLL fusion protein complexes.
    Takahashi S; Yokoyama A
    Biochim Biophys Acta Gene Regul Mech; 2020 Jul; 1863(7):194548. PubMed ID: 32320750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular mechanisms of leukemogenesis in MLL-leukemias].
    Yokoyama A
    Rinsho Ketsueki; 2011 Aug; 52(8):679-85. PubMed ID: 21897075
    [No Abstract]   [Full Text] [Related]  

  • 27. A systematic description of MLL fusion gene formation.
    Wright RL; Vaughan AT
    Crit Rev Oncol Hematol; 2014 Sep; 91(3):283-91. PubMed ID: 24787275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mixed-Phenotype Acute Leukemia: Diagnostic Criteria and Pitfalls.
    Charles NJ; Boyer DF
    Arch Pathol Lab Med; 2017 Nov; 141(11):1462-1468. PubMed ID: 29072953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reciprocal world of MLL fusions: A personal view.
    Marschalek R
    Biochim Biophys Acta Gene Regul Mech; 2020 Jul; 1863(7):194547. PubMed ID: 32294539
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recent progress toward epigenetic therapies: the example of mixed lineage leukemia.
    Neff T; Armstrong SA
    Blood; 2013 Jun; 121(24):4847-53. PubMed ID: 23649466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Defining leukemia stem cells in MLL-translocated leukemias: implications for novel therapeutic strategies.
    Faber J; Armstrong SA
    Klin Padiatr; 2007; 219(6):306-11. PubMed ID: 18050039
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In focus: MLL-rearranged leukemia.
    de Boer J; Walf-Vorderwülbecke V; Williams O
    Leukemia; 2013 Jun; 27(6):1224-8. PubMed ID: 23515098
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic targeting of MLL.
    Liedtke M; Cleary ML
    Blood; 2009 Jun; 113(24):6061-8. PubMed ID: 19289854
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Learning from mouse models of MLL fusion gene-driven acute leukemia.
    Schwaller J
    Biochim Biophys Acta Gene Regul Mech; 2020 Aug; 1863(8):194550. PubMed ID: 32320749
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatment.
    Sarno F; Nebbioso A; Altucci L
    Epigenetics; 2020 May; 15(5):439-453. PubMed ID: 31790636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNAs mark in the MLL-rearranged leukemia.
    Benetatos L; Vartholomatos G
    Ann Hematol; 2013 Nov; 92(11):1439-50. PubMed ID: 23728610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. When epigenetics kills: MLL fusion proteins in leukemia.
    Slany RK
    Hematol Oncol; 2005 Mar; 23(1):1-9. PubMed ID: 16118769
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure of AF3p21, a new member of mixed lineage leukemia (MLL) fusion partner proteins-implication for MLL-induced leukemogenesis.
    Sano K
    Leuk Lymphoma; 2001 Aug; 42(4):595-602. PubMed ID: 11697487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MLL leukemia and future treatment strategies.
    Marschalek R
    Arch Pharm (Weinheim); 2015 Apr; 348(4):221-8. PubMed ID: 25740345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Menin as a hub controlling mixed lineage leukemia.
    Thiel AT; Huang J; Lei M; Hua X
    Bioessays; 2012 Sep; 34(9):771-80. PubMed ID: 22829075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.